Bristol Myers Squibb director proposes $250K sale

The proposed sale is listed with an aggregate market value of $250,000 and an approximate sale date of November 5, 2026.

Available on EDGAR 11/06/2026 - 01:30 PM EST Accepted by SEC EDGAR 11/06/2026 - 01:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Bristol Myers Squibb Co. (BMY) director Julia A Haller Gottsch reported a proposed sale of 3,800 common shares, listed at an aggregate market value of $250,000. The proposed sale has an approximate date of November 5, 2026; Merrill Lynch is named as broker, and the listed exchange is the NYSE.

Key Figures

Shares proposed for sale: 3,800 shares Aggregate market value: $250,000 Issuer shares outstanding: 2,044,085,831 shares

3 metrics

Shares proposed for sale 3,800 shares Proposed sale by Julia A Haller Gottsch

Aggregate market value $250,000 Proposed sale

Issuer shares outstanding 2,044,085,831 shares Reported in the securities information

Key Terms

Rule 144, stock bonus, stock options

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock bonus financial

"06/13/2021 | stock bonus"

stock options financial

"06/03/2022 | stock options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BMY shares is Julia A Haller Gottsch proposing to sell?

Julia A Haller Gottsch, a director of Bristol Myers Squibb Co., reported a proposed sale of 3,800 common shares, listed at an aggregate market value of $250,000.

When is the proposed BMY share sale scheduled?

The approximate sale date is November 5, 2026. Merrill Lynch is named as broker, and the listed exchange is the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001656082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRISTOL MYERS SQUIBB CO
SEC File Number	001-01136
Address of Issuer	2 Contra Way T2L Merrimack NEW HAMPSHIRE 03054
Phone	8008230217
Name of Person for Whose Account the Securities are To Be Sold	Julia A Haller Gottsch
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 901 Dulaney Valley Rd Suite 516 Towson MD 21204	3800	250000	2044085831	11/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/13/2021	stock bonus	Bristol- Myers Squibb			851	06/13/2021	stock options
common stock	06/03/2022	stock bonus	Bristol- Myers Squibb			2949	06/03/2022	stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ashley Rowett
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)